Zobrazeno 1 - 10
of 277
pro vyhledávání: '"T. Michalski"'
Autor:
T. Michalski
Publikováno v:
Acta Societatis Botanicorum Poloniae, Vol 24, Iss 1, Pp 181-188 (2017)
Externí odkaz:
https://doaj.org/article/d1958cd10101403c9acd6bd0450e3a45
Publikováno v:
Plant, Soil and Environment, Vol 62, Iss 3, Pp 135-142 (2016)
This article demonstrates the influence of the method using application of 100 kg N/ha of nitrogen fertilizer and hybrid types of maize (Zea mays L.) on selected efficiency indicators used for this macroelement. It was shown that in comparison to tra
Externí odkaz:
https://doaj.org/article/1a7c3a9f0a644f9aa5e4f9dd7fe38dd4
Autor:
Carlos Andrés Ossa Gomez, Maria Isabel Achatz, Mabel Hurtado, María Carolina Sanabria-Salas, Yasser Sullcahuaman, Yanin Chávarri-Guerra, Julie Dutil, Sarah M. Nielsen, Edward D. Esplin, Scott T. Michalski, Sara L. Bristow, Kathryn E. Hatchell, Robert L. Nussbaum, Daniel E. Pineda-Alvarez, Patricia Ashton-Prolla
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSETo report on pathogenic germline variants detected among individuals undergoing genetic testing for hereditary breast and/or ovarian cancer (HBOC) from Latin America and compare them with self-reported Hispanic individuals from the United Stat
Externí odkaz:
https://doaj.org/article/43db6d9fc94e42e6a1310cb54ca51222
Autor:
Brandie, Heald, Sara, Mokhtary, Sarah M, Nielsen, Susan, Rojahn, Shan, Yang, Scott T, Michalski, Edward D, Esplin
Publikováno v:
Gynecologic Oncology. 166:344-350
Hereditary uterine cancer (UC) is traditionally associated with pathogenic/likely pathogenic germline variants (PGVs) in Lynch syndrome genes or PTEN; however, growing evidence supports a role for other genes that may reveal new clinical management o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f5b2f542e91c3e8de77d79586d1c7c
https://doi.org/10.1016/j.ygyno.2022.05.023
https://doi.org/10.1016/j.ygyno.2022.05.023
Autor:
Scott T. Michalski, Sonia S. Kupfer, Sarah M. Nielsen, Charles Muller, Kathryn E. Hatchell, Edward D. Esplin, Barbara Hamlington, Robert L. Nussbaum, Shan Yang
Publikováno v:
JCO Precision Oncology
PURPOSE Strict clinical criteria used by Medicare for germline testing for Lynch syndrome (LS) could lead to missed diagnoses of hereditary cancer syndromes given variable individual and family phenotypes. The aim of this study was to compare rates a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837a5b560dde8610e924121a82564de5
https://doi.org/10.1200/po.21.00132
https://doi.org/10.1200/po.21.00132
Autor:
Whitney, Espinel, Marjan, Champine, Heather, Hampel, Joanne, Jeter, Kevin, Sweet, Robert, Pilarski, Rachel, Pearlman, Kate, Shane, Pamela, Brock, Judith A, Westman, Lindsay, Kipnis, Jilliane, Sotelo, Anu, Chittenden, Samantha, Culver, Jill E, Stopfer, Katherine A, Schneider, Rosalba, Sacca, Diane R, Koeller, Shraddha, Gaonkar, Erica, Vaccari, Sarah, Kane, Scott T, Michalski, Shan, Yang, Sarah M, Nielsen, Sara L, Bristow, Stephen E, Lincoln, Robert L, Nussbaum, Edward D, Esplin
Publikováno v:
Cancers. 14(10)
Consensus guidelines for hereditary breast and ovarian cancer include management recommendations for pathogenic/likely pathogenic (P/LP) variants in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24cf0bd64bd4582859098cbce772d872
https://pubmed.ncbi.nlm.nih.gov/35626031
https://pubmed.ncbi.nlm.nih.gov/35626031
Autor:
J. Kevin Hicks, Scott T. Michalski, Hio Chung Kang, Darcy K. Berry, Xia Wang, Shan Yang, Howard L. McLeod, Benjamin C. Creelan
Publikováno v:
JCO Precis Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6847f0f60611d454925c22e0e87a4f01
https://doi.org/10.1200/po.19.00297
https://doi.org/10.1200/po.19.00297
Autor:
Robert L. Nussbaum, Shan Yang, Ihn Young Song, Scott T. Michalski, Daniel E. Pineda-Alvarez, Meaghan Russell, Edward D. Esplin
Publikováno v:
Cancer Research. 80:P2-09
Background: With the rise of precision medicine, hereditary cancer germline testing and tumor genetic testing have been increasingly used to inform the management of patients with cancer. Recent studies report that approximately 10% of patient’s tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a07d81e56d27f660b57fb8715af233d
https://doi.org/10.1158/1538-7445.sabcs19-p2-09-08
https://doi.org/10.1158/1538-7445.sabcs19-p2-09-08
Autor:
Scott T. Michalski, Emily R. Soper, Michael J. Anderson, Rashmi Tondon, Anil K. Rustgi, Dana Farengo Clark, Sarah Kate Hughes, Bryson W. Katona, Bita Nehoray, Susan M. Domchek, Jessica Ebrahimzadeh, Daniel E. Pineda-Alvarez
Publikováno v:
Genetics in Medicine
Purpose CTNNA1 is a potential diffuse gastric cancer risk gene, however CTNNA1 testing on multigene panel testing (MGPT) remains unstudied. Methods De-identified data from 151,425 individuals who underwent CTNNA1 testing at a commercial laboratory be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9cc0b80549c55e58f80d3e64823f1b
http://europepmc.org/articles/PMC7200596
http://europepmc.org/articles/PMC7200596
Publikováno v:
Cancer Research. 80:P6-08
Background: A variety of studies have examined the prevalence of germline mutations in patients undergoing genetic testing for a wide variety of breast cancer predisposition genes. Many of these studies have focused on patients of Northern European d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e561d0e848048218fccabf857cc658a0
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-19
https://doi.org/10.1158/1538-7445.sabcs19-p6-08-19